Logic Leveraged retweeted
A resume came across my desk this morning
Class of 2030
Expected GPA: 4.00 / 4.00
Not current. Expected.
Hasn’t taken a single exam
Didn’t read the rest
Kid is projecting a perfect four-year performance with zero actuals, no cushion, and no plan to revise
That’s not a student. That’s a CFO.
Hired on the spot. Start date Monday.
First assignment is the Q4 forecast
Sent from my iPhone
Logic Leveraged retweeted
Lululemon Crashes After Another Brutal Guidance Cut; Jefferies Flags "Triple Whammy" Quarter zerohedge.com/markets/lulule…
It's over
Memory, photonics, and neoclouds already ran.
THE NEXT $1T AI BOTTLENECK IS CYBERSECURITY.
Humanity just opened Pandora's box.
What we let out is unlike any threat we've ever seen. And these 10 stocks might be our only hope.
1) $CRWD
The control plane every AI agent has to pass through. Record $1.47 billion quarter, up 26%. Net new ARR hit $333 million, up 51%. George Kurtz just said AIDR can be bigger than EDR because each person will run ~90 agents. The market still prices CrowdStrike like an endpoint vendor. Kurtz is describing the security layer for the agent era.
Logic Leveraged retweeted
levels to the game in consumer L/S alt data:
>alt data QTD SSS% is often more accurate than mgmt SSS% est -- so 3D chess becomes, "will mgmt lie," and/or imply in their SSS% guide some sequential accel due to a new product intro
>knowing which retailers have a high % of cash transactions (thus tanking RSQ on cc/alt data)
>knowing that mgmt will buy the comp and so you have SSS% upside + GM% downside, forecasted with confidence, but what u dont know is how the stock will react even if your #'s are 100% accurate.
>mgmt juicing qtr end SSS% thru some 1Q promo where expenses won't hit til 2Q ("exit rate accel"), alt data rips into q end even though promos/cannibalization are 1-2 q's away
>mgmt's ability to play games w/ the comp base (impossible to forecast as minority shareholder)...ditto remodels, relos, expansions (remodels inflate comps in entering comp base), or excluding one-off weather/disruption events
>mgmt's ability to play games w/ omni + ecom sales in triangulating consolidated SSS%...stores soft, ecom strong, report "blended comp" w minimal disclosure otherwise
>ditto bopis/curbside/ship from store...ditto what store an ecom sale gets assigned to...ditto return rates (book sales 1Q juiced by promos, returns hit 2Q)
>also conversion of franchise/licensed stores. sometimes its in the 10Q but the stock has moved by then, #'s moved, u aint getting paid
>getting the quarter right, the guide right (say 1Q/2Q), and then the 2H guide is trash for reasons u could never have alt data'd your way into
>timing of aging inventory/channel stuffing (will inv be marked down in 3 mo, 6 mo, unclear)
>mgmt channel shift disclosure (wholesale/DTC) - lot of room to obfuscate revs/GM%s/fixed cost deleverage
>accounting for loyalty/gift-card/card credit programs to boost ebit/eps
>data is just straight up fucking wrong because what the fuck do they care, you're paying for it anyway
$FIVE short the stock the squishy dumpling bullshit is over and the whisper is WAY above guidance...
lots of supply from unnatural common stock holders coming on monday $NBIS
$ALB the Chinese output doesn't fucking matter. Look at the 2027 demand.
Logic Leveraged retweeted
MODERNA, MERCK MRNA CANCER VACCINE SUCCEEDS IN PHASE 3
$MRNA and $MRK say their personalized mRNA cancer vaccine, intismeran, combined with Keytruda slowed melanoma recurrence and spread in a late-stage trial.
The study was stopped at its first interim analysis after positive results, though detailed efficacy data have not yet been released.
If the benefit holds up, this would mark the first randomized Phase 3 validation of a personalized neoantigen cancer vaccine and could significantly broaden the use of mRNA technology beyond traditional vaccines.
Logic Leveraged retweeted
Guggenheim bonds cratering
Logic Leveraged retweeted
Another hangup I'm seeing: why did Jane Street have long momentum exposure? Not because they're yoloing a factor. Because many stat arb strategies organically accrue momentum exposure and residualizing it out would reduce risk-adjusted returns.
A stylized example with no IP since it's in the literature: your signal is xsection(analyst earnings revision). Long equities with upside revision acceleration, short equities with downside revision acceleration. This is _not_ a bet on price continuation/trend.
However! Analysts empirically cluster around news that has already moved the price. The legitimate fundamental information seeding the cross-section has a latent loading on momentum, via human behavior.
If you try to orthogonalize this signal to momentum, you linearly downweight the equities in the cross-section which report the highest analyst conviction, because that conviction is mechanically reflexive on momentum, even though it is a qualitatively distinct source of information!
Consequently, your residualization will flatten the distribution: post-resid top quintile of the xsection has shifted names with weaker signal from the middle three quintiles, and likewise for the bottom quintile.
Realistic numbers - you squeeze a 1.0 Sharpe out of analyst revisions, 8% annualized on 8% vol. You residualize out momentum, your vol does drop because you took out the momentum risk. Maybe it goes to 6%. But oops - because of the distribution smearing effect, your returns have fallen faster, to around 5%, and now you've got like a 0.85 Sharpe.
Jane Street are not idiots. They understand this intimately well, and far better than I'm even describing here. They're still up $40B net revenue YTD after losing $15B because they rationally accept the higher risk adjusted returns that keep in the factor prone to sharp drawdowns.
Additionally, retail sales this AM printed strong MoM numbers for all core categories. Probably will see a bid into earnings... $BBWI
I like $BBWI going into earnings. 6.5x forward P/E and 7.8% short interest, the Q2 bar is deeply depressed. Body care and lean inventory set up an easy beat while ~15% FCF yield and derisked debt runway anchor the bottom.
I like $BBWI going into earnings. 6.5x forward P/E and 7.8% short interest, the Q2 bar is deeply depressed. Body care and lean inventory set up an easy beat while ~15% FCF yield and derisked debt runway anchor the bottom.
All of software now has the LBO bid and can rerate to 20x FCF... kinda.. $WDAY
























